Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Am Heart J. 2012 Oct;164(4):607–615. doi: 10.1016/j.ahj.2012.07.004

Table III.

Antithrombotic use stratified by ACS and PCI status.

Medications ACS (n = 1133),
n (%)
PCI (n = 551),
n (%)
None 39 (3.4) 0 (0.0)
Antiplatelet therapy alone* 703 (62.1) 459 (83.3)
Aspirin and clopidogrel 519 (45.8) 538 (97.6)
Warfarin only 22 (1.9) 0 (0.0)
Warfarin and antiplatelet therapy* 369 (32.6) 92 (16.7)
*

Antiplatelet therapy defined as aspirin, clopidogrel, or both.